Cutad, Baby Girl .
HRN: 26-76-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2025
03/09/2025
IV
15mg
Q36
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes